Dietary coenzyme Q10 does not protect against cigarette smoke-augmented atherosclerosis in apoE-deficient mice

Free Radical Biology and Medicine

Volumn 48, Issue 11, 2010, Pages 1535-1539

  Gairola, C Gary ^a   Howatt, Deborah A ^a   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cigarette smoke; Coenzyme Q10; Dietary antioxidant; Mouse model

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CIGARETTE SMOKE; ETHOXYRESORUFIN DEETHYLASE; SATURATED FATTY ACID; UBIDECARENONE;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HYPERLIPOPROTEINEMIA TYPE 3; LIPID DIET; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; CYTOCHROME P-450 CYP1A1; DIET; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE; SMOKE; UBIQUINONE;

MUS;

EID: 77952546715     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.035     Document Type: Article

References (36)

1. Steinberg D., Lewis A. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation 1997, 95:1062-1071.
2. Daugherty A., Roselaar S.E. Lipoprotein oxidation as a mediator of atherogenesis: Insights from pharmacological studies. Cardiovasc. Res. 1995, 29:297-311.
3. Heinecke J.W. Oxidized amino acids: Culprits in human atherosclerosis and indicators of oxidative stress. Free Radic. Biol. Med. 2002, 32:1090-1101.
4. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury - Part I: Basic mechanisms and in vivo monitoring of ROS. Circulation 2003, 108:1912-1916.
5. Powell J.T. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc. Med. 1998, 3:21-28.
6. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2003, 180:121-137.
7. Burke A., Fitzgerald G.A. Oxidative stress and smoking-induced vascular injury. Prog. Cardiovasc. Dis. 2003, 46:79-90.
8. Kritharides L., Stocker R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis 2002, 164:211-219.
9. Salonen J.T. Clinical trials testing cardiovascular benefits of antioxidant supplementation. Free Radic. Res. 2002, 36:1299-1306.
10. Clarke R., Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc. Drugs Ther. 2002, 16:411-415.
11. Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 2003, 24:471-478.
12. Knight-Lozano C.A., Young C.G., Burow D.L., Hu Z.Y., Uyeminami D., Pinkerton K.E., Ischiropoulos H., Ballinger S.W. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002, 105:849-854.
13. Ballinger S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 2005, 38:1278-1295.
14. James A.M., Smith R.A.J., Murphy M.P. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch. Biochem. Biophys. 2004, 423:47-56.
15. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995, 1271:195-204.
16. Littarru G.P., Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol. Biotechnol. 2007, 37:31-37.
17. Bhagavan H.N., Chopra R.K. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res. 2006, 40:445-453.
18. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 Protects Human Low Density Lipoprotein More Efficiently Against Lipid Peroxidation Than Does alpha-Tocopherol. Proc. Natl. Acad. Sci. USA 1991, 88:1646-1650.
19. Pepe S., Marasco S.F., Haas S.J., Sheeran F.L., Krum H., Rosenfeldt F.L. Coenzyme Q10 in cardiovascular disease. Mitochondrion 2007, 7:S154-S167.
20. Lönnrot K., Holm P., Lagerstedt A., Huhtala H., Alho H. The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice. Biochem. Mol. Biol. Int. 1998, 44:727-737.
21. Kwong L.K., Kamzalov S., Rebrin I., Bayne A.V., Jana C.K., Morris P., Forster M.J., Sohal R.S. Effects of coenzyme Q10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic. Biol. Med. 2002, 33:627-638.
22. Witting P.K., Petersson K., Letters J., Stocker R. Anti-atherogenic effect of coenzyme Q(10) in apolipoprotein E gene knockout mice. Free Radic. Biol. Med. 2000, 29:295-305.
23. Thomas S.R., Leichtweis S.B., Pettersson K., Croft K.D., Mori T.A., Brown A.J., Stocker R. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb. Vasc. Biol. 2001, 21:585-593.
24. Gairola C.G., Drawdy M.L., Block A.E., Daugherty A. Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E-/- mice. Atherosclerosis 2001, 156:49-55.
25. nd Hand Smoking. Molecular Mechanisms of Tobacco-induced Diseases 2006, 121-132. Nova Science Publishers, NY. X.L. Wang, D.A. Scott (Eds.).
26. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 2000, 105:1605-1612.
27. Okamoto T., Fukui K., Nakamoto M., Kishi T., Okishio T., Yamagami T., Kanamori N., Kishi H., Hiraoka E. High-performance liquid chromatography of coenzyme Q-related compounds and its application to biological materials. J. Chromatogr. 1985, 342:35-46.
28. Daugherty A., Whitman S.C. Quantification of atherosclerosis in mice. Methods Mol. Biol. 2003, 209:293-309.
29. Daugherty A., Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 2005, 36:129-138.
30. Saraff K., Babamusta F., Cassis L.A., Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1621-1626.
31. Maresh J.G., Xu H., Jiang N., Gairola C.G., Shohet R.V. Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo. Physiol. Genomics 2005, 21:308-313.
32. Dallner G., Sindelar P.J. Regulation of ubiquinone metabolism. Free Radic. Biol. Med. 2000, 29:285-294.
33. Kamzalov S., Sumien N., Forster M.J., Sohal R.S. Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice. J. Nutr. 2003, 133:3175-3180.
34. Heitzer T., Just H., Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996, 94:6-9.
35. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996, 94:19-25.
36. Rader D.J., Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008, 241:904-913.